AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today

As members of Congress return to their districts for Easter recess, AARP is kicking off a new phase of its Fair Drug Prices Now campaign and pushing lawmakers to advance the prescription drug pricing provisions, including allowing Medicare to negotiate, already passed by the House, as a top priority when they return.

Today AARP launched new television and digital advertising featuring Larry Zarzecki, a retired law enforcement officer with Parkinson’s disease who was forced to sell his home in order to afford his medications. Zarzecki first shared his story in an AARP ad three years ago, but Congress’ failure to act means he has had no relief from the high cost of his treatments. As he says in the new ad, “I shouldn’t have to decide between my home or my medicine because Congress refuses to act. I’m tired of waiting for Congress.”

AARP CEO Jo Ann Jenkins released the following statement in response to President Biden’s State of the Union speech this evening, during which he called for action on high drug prices and announced new policies to improve nursing home care

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to President Biden’s remarks today about the need to lower prescription drug prices

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement about Medicare enrollees soon having access to at-home COVID tests at no cost:

AARP CEO Jo Ann Jenkins issued the following statement reacting to the announcement of a deal to lower prescription drug costs

AARP Chief Executive Officer Jo Ann Jenkins released the following statement in response to today’s announcement of the 2022 cost-of-living adjustment (COLA) in Social Security benefits

AARP has launched a full-scale campaign, including a $4 million ad buy, pushing back on false claims from the pharmaceutical industry that reforms would limit Americans’ access to medicines. AARP has called for fair drug prices for years and is urging Congress to pass legislation that would allow Medicare to negotiate drug prices, put a cap on out-of-pocket costs that older adults pay for their prescription drugs and impose penalties on drug companies that raise prices faster than the rate of inflation.

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today